BioCardia (BCDAW) Competitors

$0.02
0.00 (0.00%)
(As of 04/29/2024 ET)

BCDAW vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCTXW, CDIOW, CTCXW, SAVAW, and CELUW

Should you be buying BioCardia stock or one of its competitors? The main competitors of BioCardia include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Cassava Sciences (SAVAW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry.

BioCardia vs.

BioCardia (NASDAQ:BCDAW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, community ranking, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

BioCardia and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
BioCardiaN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioCardia$477KN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

In the previous week, 180 Life Sciences had 1 more articles in the media than BioCardia. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for BioCardia. 180 Life Sciences' average media sentiment score of 1.00 beat BioCardia's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
BioCardia Neutral
180 Life Sciences Positive

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BioCardia
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Company Net Margins Return on Equity Return on Assets
BioCardiaN/A N/A N/A
180 Life Sciences N/A N/A N/A

Summary

180 Life Sciences beats BioCardia on 2 of the 3 factors compared between the two stocks.

Get BioCardia News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCDAW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BCDAW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BCDAW vs. The Competition

MetricBioCardiaBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$200.58M$4.79B$7.61B
Dividend YieldN/A3.48%5.34%3.95%
P/E RatioN/A238.86168.0313.85
Price / SalesN/A15,401.862,532.0185.28
Price / CashN/A11.4531.7327.95
Price / BookN/A5.664.614.28
Net IncomeN/A-$21.94M$101.20M$213.46M
7 Day PerformanceN/A1.16%-0.13%0.69%
1 Month PerformanceN/A-4.03%-7.58%-5.12%
1 Year PerformanceN/A-4.53%6.00%7.25%

BioCardia Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATNFW
180 Life Sciences
0 of 5 stars
$0.01
flat
N/A-43.3%$0.00N/A0.004Positive News
Gap Down
SXTPW
60 Degrees Pharmaceuticals
0 of 5 stars
$0.11
flat
N/AN/A$0.00$253,573.000.002Gap Down
DRTSW
Alpha Tau Medical
0 of 5 stars
$0.23
flat
N/A-6.9%$0.00N/A0.00121Positive News
Gap Down
APLMW
Apollomics
0 of 5 stars
$0.02
-34.5%
N/AN/A$0.00N/A0.0059Short Interest ↓
Gap Down
ARTLW
Artelo Biosciences
0 of 5 stars
$0.01
flat
N/AN/A$0.00N/A0.006Gap Down
BCTXW
BriaCell Therapeutics
0 of 5 stars
$0.91
-3.2%
N/A-69.8%$0.00N/A0.0016Gap Down
CDIOW
Cardio Diagnostics
0 of 5 stars
$0.08
flat
N/A-62.9%$0.00$17,065.000.007Gap Up
CTCXW
Carmell
0 of 5 stars
$0.08
flat
N/AN/A$0.00$3.73M0.009Gap Up
SAVAW
Cassava Sciences
0 of 5 stars
$0.38
-11.6%
N/AN/A$0.00N/A0.0029Gap Down
CELUW
Celularity
0 of 5 stars
$0.04
flat
N/A-43.6%$0.00$14.79M0.00225

Related Companies and Tools

This page (NASDAQ:BCDAW) was last updated on 4/30/2024 by MarketBeat.com Staff

From Our Partners